Aptus Capital Advisors, LLC Edwards Lifesciences Corp Transaction History
Aptus Capital Advisors, LLC
- $6.27 Billion
- Q3 2024
A detailed history of Aptus Capital Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 7,949 shares of EW stock, worth $599,195. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,949
Previous 8,171
2.72%
Holding current value
$599,195
Previous $754,000
30.5%
% of portfolio
0.01%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding EW
# of Institutions
1,350Shares Held
457MCall Options Held
9.76MPut Options Held
3.92M-
Vanguard Group Inc Valley Forge, PA62.6MShares$4.72 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.84 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA31.5MShares$2.38 Billion0.37% of portfolio
-
State Street Corp Boston, MA26.3MShares$1.98 Billion0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA13.5MShares$1.02 Billion0.07% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $46.6B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...